![Claus Juan Møller-San Pedro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claus Juan Møller-San Pedro
Directeur/Membre du Conseil chez
Terranol A/S
Profil
Claus Juan Møller-San Pedro was the founder of I.
P.
Cons ApS (1994) and Azanta A (1994), where he held the titles of Chief Executive Officer and Managing Director, respectively.
He is currently a Director at Terranol A. Dr. Møller-San Pedro's former positions include Director at EpiTherapeutics ApS, Medical Director at Synthélabo Scandinavia A, Director, Chief Executive & Commercial Officer at Y-mAbs Therapeutics, Inc., Executive VP, Chief Operating & Medical Officer at Oncotelic Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genmab A, and President at IPC Corp.
Ltd. Dr. Møller-San Pedro holds a doctorate degree from the University of Copenhagen.
Postes actifs de Claus Juan Møller-San Pedro
| Sociétés | Poste | Début |
|---|---|---|
Terranol A/S
 Terranol A/S Miscellaneous Commercial ServicesCommercial Services Provides yeasts for bioethanol production | Directeur/Membre du Conseil | 08/07/2009 |
Anciens postes connus de Claus Juan Møller-San Pedro
| Sociétés | Poste | Fin |
|---|---|---|
| YMAS THER | Directeur Général | 22/04/2022 |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Directeur Général | 01/01/2015 |
| GENMAB A/S | Directeur des opérations | 01/01/2008 |
I. P. Cons ApS
 I. P. Cons ApS Real Estate DevelopmentFinance Leases property and equipment; and provides investment services | Directeur Général | - |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Directeur/Membre du Conseil | - |
Formation de Claus Juan Møller-San Pedro
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
IPC Corp. Ltd.
 IPC Corp. Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates as an investment holding company with interest in providing hotel management and property selling services | Consumer Services |
I. P. Cons ApS
I. P. Cons ApS Real Estate DevelopmentFinance Leases property and equipment; and provides investment services | Finance |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terranol A/S
Terranol A/S Miscellaneous Commercial ServicesCommercial Services Provides yeasts for bioethanol production | Commercial Services |
EpiTherapeutics ApS
EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Synthélabo Scandinavia A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
